Abstract
Background Cardiac resynchronization therapy (CRT) is an established therapy. There are two techniques to implant the left ventricular (LV) lead i.e. transvenous implantation (TI) via the coronary sinus and surgical implantation using left lateral minithoracotomy (LLM). This study was designed to compare the procedures, treatment results as well as complications. Methods In this study we included 81 patients (pat.). All pat. received right atrial and ventricular lead using established TI techniques. The LV lead was positioned via the coronary sinus (59 pat.) or via LLM epimyocardially (22 pat.). Baseline evaluation included assessment of NYHA functional class, electrocardiogram and echocardiography. These measurements were repeated during the follow-ups (FU). Additionally data on the procedure as well as perioperative data was collected. Results Both groups showed significant improvement in NYHA (3,2±0,4 to 2,0±0,6, p<0,001) as well as in the LV-ejection fraction by 22 percent (p<0,001). The TI group had an average implantation time of 134±46,8 minutes. Pat. with LLM had an average operation time of 116,6±48,7 minutes. Intensive care unit (ICU) treatment after implantation were 1,3±1,6 days (TI) versus 3,4±3 days in the epimyocardial group (p<0,001). Postoperative stay was significantly longer in the epimyocardial group (9,4±6,4 days) compared to 6,1±3,1 days (p<0.001) (TI). No deaths occurred intra- or perioperative in the hospital. No significant differences were found during further FU. Conclusion The transvenous positioning of the lead does have prolonged procedure time, longer x-ray time and higher incidence of reinterventions due to lead dislocations compaired to epimyocardial implantation. However, the results of this study suggest that pat. who are eligible for CRT should receive their LV lead as a primary procedure transvenously due to less trauma, local anesthesia, less ICU treatment, less days in hospital and consequentially lower costs for an implantation. To receive comparatively results a prospective randomized study is necessary.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.